Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2002
10/10/2002WO2002079451A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079445A2 Transgenic mice containing kallikrein-like gene disruptions
10/10/2002WO2002079444A2 Transgenic mice containing msk2 serine/threonine kinase gene disruptions
10/10/2002WO2002079442A2 Transgenic mice containing ubiquitin enzyme gene disruptions
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079433A2 Transgenic mice containing tmem3 beta-1,3-n-acetylglucosaminyltransferase gene disruptions
10/10/2002WO2002079431A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/10/2002WO2002079430A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079424A2 TRANSGENIC MICE CONTAINING β3GALT2 GENE DISRUPTIONS
10/10/2002WO2002079421A2 Transgenic mice containing p19-ptp protein tyrosine phosphatase gene disruptions
10/10/2002WO2002079420A2 Adam-like protease disruptions, compositions and methods related thereto
10/10/2002WO2002079412A2 Transgenic mice containing usp3-like deubiquitinating enzyme gene disruptions
10/10/2002WO2002079410A2 Glucan chain length domains
10/10/2002WO2002079405A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079399A2 Regulatable growth of filamentous fungi
10/10/2002WO2002079395A2 Carotenoid biosynthesis
10/10/2002WO2002079388A2 Modulation of mhc class i antigen presentation
10/10/2002WO2002079381A2 Biosynthesis of s-adenosylmethionine in a recombinant yeast strain
10/10/2002WO2002079379A2 47153, a human glycosyltransferase family member and uses therefor
10/10/2002WO2002079258A2 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
10/10/2002WO2002079255A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
10/10/2002WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002WO2002079235A2 Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
10/10/2002WO2002079233A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/10/2002WO2002079230A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079229A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/10/2002WO2002079228A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002WO2002079226A2 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
10/10/2002WO2002079224A2 Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
10/10/2002WO2002079223A2 Covalently reactive transition state analogs and methods of use thereof
10/10/2002WO2002078737A1 Granule with reduced dust potential
10/10/2002WO2002078610A2 Pak2: modulators of lymphocyte activation
10/10/2002WO2002078438A2 Tissue-preferred promoter from maize
10/10/2002WO2002036753A3 Human triacylglycerol lipase
10/10/2002WO2002034895A3 Novel aggrecanase molecules
10/10/2002WO2002029045A3 Method for the production of vitamin k-dependent proteins
10/10/2002WO2002029025A3 Factor vii glycoforms
10/10/2002WO2002016929A3 Urokinase peptide structure mimetics
10/10/2002WO2002012481A3 Enhancement of industrial production by increasing substrate transport
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2001078787A3 Lipopolysaccharide-conjugate vaccine for sepsis treatment
10/10/2002WO2001059082A9 27802, an adenylate kinase
10/10/2002US20020148009 Genetically engineered mushroom for use in the degradation of cellulose
10/10/2002US20020148006 Transgenic plants with modified sterol compositions
10/10/2002US20020148003 Expression vector coding enzymes associated in amino acid biosynthesis for use in the generation of human and animal nutrients
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147323 Nucleotide sequences coding polypeptide for use in the treatment of bone, tumor, psychological and nervous system disorders
10/10/2002US20020147320 Novel human kinase proteins and polynucleotides encoding the same
10/10/2002US20020147305 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002US20020147172 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
10/10/2002US20020147146 Antidiabetic agents; Alzheimer's disease
10/10/2002US20020147145 Anticancer, antiproliferative agents
10/10/2002US20020147140 Nucleic acids, proteins, and antibodies
10/10/2002US20020147139 Viricides
10/10/2002US20020147133 Bifunctional molecules and therapies based thereon
10/10/2002US20020147132 Meltrins
10/10/2002US20020147123 Laundry detergent; mixture containing hydrolases as stabilizer
10/10/2002US20020146824 Novel transcription enhancer element and transcription factor and methods of use thereof
10/10/2002US20020146809 Method of making biofilms
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146804 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders
10/10/2002US20020146803 Mutant protein for use as tool in genetic engineering
10/10/2002US20020146802 Methods for producing and purifying recombinant alpha-L-iduronidase
10/10/2002US20020146799 Enzymes having esterase activity and methods of use thereof
10/10/2002US20020146798 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
10/10/2002US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002US20020146796 Thymidine kinase mutant for use as tool in killing preferential cells; for use in gene therapy
10/10/2002US20020146793 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146790 MurF
10/10/2002US20020146788 Synthetic peptide for use in the treatment of cancer, inflammation and infections
10/10/2002US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002US20020146764 Generation of preferential polypeptides; obtain expresion vector containing preferential fusion gene, express vector, recover fusion protein
10/10/2002US20020146762 Generating mutant polypeptides; obtain protein sample, incubate wih mutagen, recover and evaluate protein activity
10/10/2002US20020146757 Nucleotide sequences coding polypeptide for use in the treatment of, muscle, blood, nervous system, gastrointestinal and vision defects
10/10/2002US20020146751 fabF
10/10/2002US20020146738 Nucleotide sequences coding polypeptides for use in the treatment and prevention of infections
10/10/2002US20020146731 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
10/10/2002US20020146709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/10/2002US20020146708 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer
10/10/2002US20020146695 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
10/10/2002US20020146504 Ternary biomolecule/polymer/surface-based immobilization systems
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146420 Protein tyrosine kinase agonist antibodies
10/10/2002US20020146407 For therapy and prophylaxis of dysfunctions or diseases including, but not limited to, asthma, airway allergy, chronic obstructive pulmonary disease
10/10/2002US20020146403 Method for the treatment of bacterial eye infections
10/10/2002US20020146402 Method for the treatment of bacterial vaginal infections
10/10/2002DE10117730A1 One-pot reaction of amines, useful for preparing e.g. cyclic secondary amines or alcohols, useful as pharmaceutical intermediates, by oxidation with lysine oxidase then reduction
10/10/2002DE10114999A1 D-Carbamoylase aus Arthrobacter crystallopoietes DSM 20117 D-carbamoylase from Arthrobacter crystallopoietes DSM 20117
10/10/2002DE10114063A1 New DNA sequences from potato, useful for producing plants with altered properties, e.g. tolerance of flooding, also related proteins, antibodies and inhibitory sequences
10/10/2002CA2443211A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/10/2002CA2443198A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2443189A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
10/10/2002CA2443181A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442951A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/10/2002CA2442847A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442841A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/10/2002CA2442838A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442829A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002CA2442801A1 Recombinant antibodies coexpressed with gntiii